高知特 CTSH 深 滬
已收盤 02-06 16:00:00 美东时间
77.08
+0.240
+0.31%
華盛通- 最 高78.34
- 今 開77.27
- 成交量 441.82万股
- 最 低 76.63
- 昨 收 76.84
- 總市值 369.21亿
- 52周最高 89.07
- 市盈率 靜 16.90
- 換手率 0.92%
- 52周最低 64.59
- 委 比 -13.76%
- 總股本 4.79亿
- 歷史最高 92.56
- 量 比 0.56
- 振 幅 2.23%
- 歷史最低 32.94
- 每 手 1
- 風險率 6.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
Morgan Stanley Maintains Equal-Weight on Cognizant Tech Solns, Raises Price Target to $82
Morgan Stanley analyst James Faucette maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Equal-Weight and raises the price target from $80 to $82.
02-05 21:37
财报速睇 | 高知特 2025财年Q4营收53.33亿美元，同比增长4.9%；归母净利润6.48亿美元，同比增长18.7%
华盛资讯2月5日讯，高知特公布2025财年Q4业绩，公司Q4营收53.33亿美元，同比增长4.9%，归母净利润6.48亿美元，同比增长18.7%。
02-05 12:47
Cognizant Tech Solns Earnings Report: Q4 Overview
The earnings results for Cognizant Tech Solns (NASDAQ:CTSH) for Q4 were made pu...
02-04 21:44
Cognizant Tech Solns Sees Q1 Sales $5.360B-$5.440B vs $5.348B Est
Cognizant Tech Solns (NASDAQ:CTSH) sees Q1 sales of $5.360 billion-$5.440 billion vs $5.348 billion analyst estimate.
02-04 19:32
Cognizant Wins Seat At The Table In America's Missile Defense Overhaul
Cognizant subsidiary secures role in $151 billion defense contract for innovative capabilities under Missile Defense Agency's SHIELD program.
01-30 02:29
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
Cognizant Collaborates With Typeface To Integrate Its Delivery, Transformation Service With Typeface's Marketing Platform
Cognizant (NASDAQ: CTSH) and Typeface today announced a strategic partnership to help enterprises modernize marketing operations through agentic AI orchestration. By combining Cognizant's global delivery and
01-26 22:05
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Demystifying Cognizant Tech Solns: Insights From 8 Analyst Reviews
Ratings for Cognizant Tech Solns (NASDAQ:CTSH) were provided by 8 analysts in t...
01-23 04:00
